Zinc–selenium synergistic nanoplatform for augmented cancer immunotherapy via trace-elements-mediated immunomodulation | Synapse
January 25, 2026
Zinc–selenium synergistic nanoplatform for augmented cancer immunotherapy via trace-elements-mediated immunomodulation
Puntos clave
To investigate the potential of a zinc–selenium nanoplatform to enhance immune response in cancer therapy.
Design and synthesis of zinc–selenium nanoplatform
Assessment of immunocompetence effects
Application in cancer immunotherapy models
The nanoplatform effectively enhances immunocompetence
Demonstrated potential for safe and efficient cancer treatment
Resumen
A zinc–selenium synergistic nanoplatform was designed to potentiate immunocompetence via trace elements-mediated immunomodulation effects, enabling safe and efficient cancer immunotherapy.